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Background
Patient and public involvement (PPI), inclusion of
members of the public as active partners in the research
process, can be a requirement of research funding.
Limited evidence has suggested that clinical trials may
be particularly likely to benefit from PPI. There is a lack
of critical assessment of PPI and suggestions in the lit-
erature of selective reporting of its benefits. This study
aims to increase the knowledge of PPI in clinical trials
by systematically investigating how it is approached
within a cohort of public funded randomised trials in
the UK.
Methods
Documentation from the application process for all ran-
domised trials funded by the National Institute for Health
Research Health Technology Assessment (NIHR HTA)
programme between 2006 and 2010 were obtained. Data
relating to PPI activity and how these plans were assessed
within the peer review process were extracted.
Results
Documentation to allow details of planned PPI activity
to be extracted were available in 107 RCTs. PPI repre-
sentation was not described in 15% with representation
on TSCs, DMCs, and TMGs described in 53%, 8%, and
12% of applications respectively. A consultancy approach
was described in 26%.
Of the 515 reviewers comments across the trials only
211(41%) commented on PPI plans. The majority
repeated the PPI plans from the application rather than
commenting on their suitability.
Conclusions
Research applicants frequently describe PPI but
reviewers seem unable to comment on suitability of the
approach. Evidence of impact is needed to inform future
approaches for applicants and peer reviewers.
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